Is Heptanedicarboxylic acid Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use Heptanedicarboxylic acid? Is Heptanedicarboxylic acid safe for nursing mother and child? Does Heptanedicarboxylic acid extracts into breast milk? Does Heptanedicarboxylic acid has any long term or short term side effects on infants? Can Heptanedicarboxylic acid influence milk supply or can Heptanedicarboxylic acid decrease milk supply in lactating mothers?
Heptanedicarboxylic acid lactation summary
- DrLact safety Score for Heptanedicarboxylic acid is 1 out of 8 which is considered Safe as per our analyses.
- A safety Score of 1 indicates that usage of Heptanedicarboxylic acid is mostly safe during lactation for breastfed baby.
- Our study of different scientific research also indicates that Heptanedicarboxylic acid does not cause any serious side effects in breastfeeding mothers.
- Most of scientific studies and research papers declaring usage of Heptanedicarboxylic acid safe in breastfeeding are based on normal dosage and may not hold true for higher dosage.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
Answer by Dr. Ru: About Heptanedicarboxylic acid usage in lactation
Avoid using it on the breast or cleanse thoroughly before nursing.
Answer by DrLact: About Heptanedicarboxylic acid usage in lactation
Topical Heptanedicarboxylic acid has not been studied during breastfeeding. Because only 4% of a dose is absorbed after topical application and it is a chemical that appears in foods and the bloodstream normally, Heptanedicarboxylic acid is considered a low risk to the nursing infant.[1][2] Ensure that the infant's skin does not come into direct contact with the areas of skin that have been treated. Only water-miscible cream or gel products should be applied to the breast because ointments may expose the infant to high levels of mineral paraffins via licking.[3]
Alternate Drugs
Dactinomycin(Dangerous)
Bleomycin(Dangerous)
Carboplatin(Dangerous)
Mitoxantrone(Dangerous)
Vinorelbine(Dangerous)
Cladribine(Dangerous)
Paclitaxel(Dangerous)
Mercaptopurine(Safe)
Dacarbazine(Dangerous)
Erlotinib(Unsafe)
Fluorouracil(Dangerous)
Dasatinib(Unsafe)
Alemtuzumab(Low Risk)
Hydroxyurea(Low Risk)
Azelaic Acid(Safe)
Nilotinib(Unsafe)
Rituximab(Low Risk)
Etoposide(Dangerous)
Bevacizumab(Low Risk)
Gemcitabine(Dangerous)
Doxorubicin(Dangerous)
Thioguanine(Dangerous)
Trastuzumab(Unsafe)
Cyclophosphamide(Dangerous)
Cisplatin(Unsafe)
Imatinib(Unsafe)
Busulfan(Dangerous)
Nivolumab(Unsafe)
Docetaxel(Dangerous)
Vincristine(Dangerous)
Pazopanib(Unsafe)
Tamoxifen(Dangerous)
Letrozole(Dangerous)
Ipilimumab(Unsafe)
Vinblastine(Dangerous)
Exemestane(Dangerous)
Cetuximab(Unsafe)
Neomycin(Safe)
Pimecrolimus(Low Risk)
Oxiconazole(Safe)
Butoconazole(Safe)
Benzoyl Peroxide(Safe)
Salicylic Acid(Safe)
Azelaic Acid(Safe)
Hydroquinone(Low Risk)
Adapalene(Safe)
Glycolic Acid(Safe)
Etanercept(Safe)
Tazarotene(Low Risk)
Adalimumab(Safe)
Isotretinoin(Unsafe)
Dexamethasone, Topical(Low Risk)
Infliximab(Safe)
Miconazole(Safe)
Calcipotriene(Safe)
Ketoconazole(Safe)
Secukinumab(Low Risk)
Erythromycin(Low Risk)
Ustekinumab(Low Risk)
Dimethyl fumarate(Low Risk)
Tioconazole(Safe)
Tacrolimus(Safe)
Sulconazole(Safe)